Résultats de la recherche

Search Pages webPDF

Les résultats s’affichent automatiquement selon le filtre sélectionné.

Filtres
Communiqué de presse
Forms
Manuel des politiques opérationnelles
Page
Mots-clés
FAQ
Formulaires
Profil du fournisseur
991 résultat(s) trouvé(s)
Drug formulary listing decision – Desvenlafaxine
Indication(s)Symptomatic relief of major depressive disorder (MDD).DAC recommendationThe Drug Advisory Committee (DAC) has recommended that desvenlafaxine not be listed on…
Drug formulary listing decision – Diclofenac sodium solution 1.5%
Indication (s)Treatment of symptoms associated with osteoarthritis of the knee (duration of treatment not to exceed 3 months).DAC recommendationThe Drug Advisory Committee (…
Drug formulary listing decision – Duloxetine
Indication(s)Symptomatic relief of major depressive disorder (MDD), generalized anxiety disorder (GAD), neuropathic pain associated with diabetic peripheral neuropathy (DPN…
Drug formulary listing decision – Escitalopram
Indication(s)Treatment of major depressive disorder (MDD), generalized anxiety disorder (GAD), and obsessive compulsive disorder (OCD).Formulary statusThe Drug Advisory…
Drug formulary listing decision – HIV post-exposure prophylaxis (HIV PEP)
Indication(s)Clinical management of occupational exposure to HIV.Formulary statusThe Drug Advisory Committee (DAC) recommended antiretroviral medications emtricitabine/…